Effects of NAMI-A on Lung Metastases in Mice
Author Information
Author(s): Sonia Zorzet, Alenka Sorc, Claudia Casarsa, Moreno Cocchietto, Gianni Sava
Primary Institution: University of Trieste
Hypothesis
Can NAMI-A effectively reduce lung metastases in CBA mice with MCa mammary carcinoma when administered orally?
Conclusion
NAMI-A is effective in reducing lung metastases in mice when given orally, with no observed toxicity.
Supporting Evidence
- NAMI-A reduced lung metastasis weight by around 40% compared to untreated controls.
- Histological analysis showed no toxicity in gut epithelium or kidney.
- NAMI-A concentration in the kidney was significantly lower than after intraperitoneal treatment.
Takeaway
This study shows that a drug called NAMI-A can help shrink cancer spread in mice when taken by mouth, and it doesn't seem to make them sick.
Methodology
CBA mice with MCa mammary carcinoma were treated orally with NAMI-A for 11 days, and lung metastases were evaluated.
Limitations
The effects on primary tumor growth were not statistically significant.
Participant Demographics
CBA female mice with advanced MCa mammary carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website